bisoprolol has been researched along with Endomyocardial Fibrosis in 1 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Endomyocardial Fibrosis: A condition characterized by the thickening of the ventricular ENDOCARDIUM and subendocardium (MYOCARDIUM), seen mostly in children and young adults in the TROPICAL CLIMATE. The fibrous tissue extends from the apex toward and often involves the HEART VALVES causing restrictive blood flow into the respective ventricles (CARDIOMYOPATHY, RESTRICTIVE).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lyne, JC | 1 |
| Hayward, C | 1 |
| Wong, T | 1 |
1 other study available for bisoprolol and Endomyocardial Fibrosis
| Article | Year |
|---|---|
Images in cardiology. Cardiac magnetic resonance image of an electrocuted heart.
Topics: Adult; Biopsy, Needle; Bisoprolol; Coronary Angiography; Defibrillators, Implantable; Echocardiograp | 2008 |